RSV vaccine for older adults approved by UK medicines regulator
Arexvy could help NHS deal with virus that causes about 8,000 deaths among older people in UK each year The UK’s medicines regulator has approved the first vaccine against respiratory syncytial virus (RSV) in older adults.The virus typically causes col…